Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
Open Access
- 4 June 2018
- journal article
- research article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 6 (8), 637-646
- https://doi.org/10.1016/s2213-8587(18)30106-2
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With SulfonylureasDiabetes Care, 2012
- Muscle Dysfunction Caused by a K ATP Channel Mutation in Neonatal Diabetes Is Neuronal in OriginScience, 2010
- Efficacy and Safety of Sulfonylurea Use in Permanent Neonatal Diabetes Due to KCNJ11 Gene Mutations: 34-Month Median Follow-UpDiabetes Technology & Therapeutics, 2010
- Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood DiabetesPediatric Diabetes, 2009
- A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular EventsDiabetes Care, 2007
- Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 MutationsNew England Journal of Medicine, 2006
- Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotypeDiabetologia, 2006
- Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal DiabetesNew England Journal of Medicine, 2004
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications TrialDiabetes Care, 1988